Autoantibody Level Modification in Adult Patients with Idiopathic Thrombocytopenic Purpura following Intravenous Immunoglobulin Treatment

Publisher： Karger

E-ISSN： 1423-0178|16|5-6|207-214

ISSN： 1018-8916

Source： Natural Immunity, Vol.16, Iss.5-6, 2000-09, pp. : 207-214

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Randomized Trial of Anti-D Immunoglobulin versus Low-Dose Intravenous Immunoglobulin in the Treatment of Childhood Chronic Idiopathic Thrombocytopenic Purpura

By  

Acta Haematologica, Vol. 115, Iss. 1-2, 2006-01 ,pp. : 46-52

Karger

Access to resources Recommend Favorite

Efficacy and Safety of the New Intravenous Immunoglobulin IGIV 10% in Adults with Chronic Idiopathic Thrombocytopenic Purpura

By  

Transfusion Medicine and Hemotherapy, Vol. 33, Iss. 6, 2006-10 ,pp. : 509-514

Karger

Access to resources Recommend Favorite

Clinical Properties of a Novel Liquid Intravenous Immunoglobulin: Studies in Patients with Immune Thrombocytopenic Purpura and Primary Immunodeficiencies

By  

Transfusion Medicine and Hemotherapy, Vol. 31, Iss. 3, 2004-06 ,pp. : 126-134

Karger

Access to resources Recommend Favorite

Treatment of idiopathic thrombocytopenic purpura in the elderly: A challenge for geriatricians

By  

GERIATRICS & GERONTOLOGY INTERNATIONAL, Vol. 15, Iss. 7, 2015-07 ,pp. : 928-929

John Wiley & Sons Inc

Access to resources Recommend Favorite

Intravenous immunoglobulin as salvage therapy for refractory thrombotic thrombocytopenic purpura

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 93, Iss. 3, 2018-03 ,pp. : E77-E79

John Wiley & Sons Inc

Access to resources Recommend Favorite